Tuba Yuce Inel | Immunology and Microbiology | Best Researcher Award

Posted on by World Top Scientists

Dr. Tuba Yuce Inel | Immunology and Microbiology | Best Researcher Award

MD at Izmir City Hospital, Turkey

Dr. Tuba Yüce İnel is a dedicated physician and researcher specializing in internal medicine, immunology, and rheumatology. With extensive experience in clinical practice and academic research, she has contributed significantly to the study of autoimmune diseases, inflammatory conditions, and rheumatological disorders. Her research focuses on understanding disease mechanisms and improving treatment approaches for complex conditions such as systemic sclerosis, ankylosing spondylitis, and rheumatoid arthritis. Dr. İnel has published multiple papers in high-impact international journals, providing valuable insights into disease management and patient outcomes. Actively involved in scientific collaborations, she has participated in various national research projects aimed at advancing rheumatological medicine. She has also been recognized for her contributions with prestigious awards, highlighting her expertise and commitment to medical science.

Professional Profile

Education

Dr. Tuba Yüce İnel began her medical education at Hacettepe University School of Medicine, where she earned her Bachelor’s degree in Medicine in 2012. She then pursued a specialization in internal medicine at Istanbul University Faculty of Medicine, completing her training in 2017 with a thesis on the side effects of immunosuppressive treatments in primary glomerular diseases. Her academic journey continued with a minor specialization in Immunology and Rheumatology at Dokuz Eylül University, where she completed her training in 2022. Through her education at leading Turkish medical institutions, Dr. İnel gained extensive clinical expertise and research experience, shaping her career in autoimmune and inflammatory diseases.

Professional Experience

Dr. İnel has held key positions as a Research Assistant at both Istanbul University (2012-2017) and Dokuz Eylül University (2018-present), where she has contributed to research and medical education. She has played a significant role in clinical studies related to autoimmune diseases, particularly focusing on systemic sclerosis and inflammatory pathways. Additionally, she has been actively involved in teaching and mentoring medical students and residents, sharing her expertise in rheumatology and immunology. Her professional journey includes participation in several government-funded scientific research projects, further solidifying her role as a leading researcher in rheumatology.

Research Interests

Dr. İnel’s research focuses on autoimmune diseases, inflammatory rheumatologic disorders, and immunology, with a particular emphasis on systemic sclerosis, ankylosing spondylitis, and rheumatoid arthritis. She has explored the role of immune pathways, including the NEK7-NLRP3 inflammasome pathway, in disease progression and treatment response. Her studies on plasma arginine-citrulline levels in systemic sclerosis have contributed to understanding disease severity and malabsorption mechanisms. Additionally, her research on obesity’s impact on ankylosing spondylitis treatment has provided real-world data on therapeutic outcomes. She continues to investigate novel biomarkers and targeted treatments to improve patient care and enhance therapeutic strategies in rheumatology.

Awards and Honors

Dr. İnel’s outstanding research has earned her recognition and accolades within the medical community. In 2022, she won the First Prize for Oral Presentation in Spondyloarthritis, awarded by the Turkish Rheumatology Association, highlighting her excellence in presenting groundbreaking research. Her work has been published in internationally recognized journals, showcasing her significant contributions to rheumatology and immunology. She is also an active member of the Turkish Rheumatology Association, reflecting her commitment to advancing knowledge and collaboration in her field. Through her academic achievements, research excellence, and clinical expertise, Dr. İnel continues to establish herself as a leading figure in rheumatology research.

Conclusion

Dr. Tuba Yüce İnel is a strong candidate for the Best Researcher Award due to her academic achievements, impactful research in rheumatology, national recognition, and continuous contributions to scientific literature. If she enhances international collaborations, takes leadership roles in research projects, and secures external funding, her candidacy would become even more compelling.

Publications Top Noted

1. A Life-Threatening Manifestation of Granulomatosis with Polyangiitis: Subglottic Stenosis

  • Authors: Yüce-İnel, T., Uslu, S.
  • Year: 2024
  • Journal: Archives of Rheumatology
  • Citations: 0

2. Assessing Safety and Efficacy of TNFi Treatment in Late-Onset Ankylosing Spondylitis: A TURKBIO Registry Study

  • Authors: Uslu, S., Gülle, S., Sen, G., Akkoç, N., Onen, F., Yüce-İnel, T.
  • Year: 2024
  • Journal: Scientific Reports
  • Citations: 4

 

Christy Echakachi Manyi-Loh | Microbiology | Women Researcher Award

Posted on by World Top Scientists

Dr. Christy Echakachi Manyi-Loh | Microbiology | Women Researcher Award

Part time lecturer/postdoctoral research fellow, Faculty of Health and Environmental Sciences, Department of Life Sciences, Central University of Technology, Bloemfontein, Free State, South Africa

Christy Echakachi Manyi-Loh is a dedicated researcher and educator in the field of microbiology, currently serving as a part-time lecturer in the Department of Life Sciences at the Central University of Technology in Bloemfontein, South Africa. Born on August 6, 1982, in Cameroon, she has built a remarkable career centered on antimicrobial resistance and renewable energy, showcasing her commitment to addressing public health concerns through her research initiatives.

Profile

Scopus

Education 🎓

Christy’s academic journey began at the University of Buea in Cameroon, where she earned her Bachelor of Science in Microbiology (2000-2003) and a Master of Science in Microbiology (2004-2007), graduating with a GPA of 3.14/4. She then pursued her Doctorate at the University of Fort Hare in South Africa, completing her Ph.D. in Microbiology from 2009 to 2012. Her extensive education laid the foundation for her expertise in microbiology, particularly in the areas of environmental and applied microbiology.

Experience 💼

With over two decades of experience in academia and research, Christy has held various positions. She has worked as a tutor and demonstrator at the University of Fort Hare, where she honed her teaching skills from 2010 to 2012. Currently, she balances her role as a part-time lecturer at the Central University of Technology with postdoctoral fellowships focusing on food safety culture and renewable energy. Her managerial experience includes overseeing a daycare center and serving as the General Manager of S and L TECH (Pty), where she is involved in editing and proofreading.

Research Interests 🔬

Christy’s research interests encompass antimicrobial resistance, natural products, renewable energy, and the microbial dynamics involved in biogas production. She has managed multiple interdisciplinary research projects, focusing on the health implications of microbial contamination in food and the efficacy of biogas technology in energy generation and waste management. Her work is characterized by a strong emphasis on sustainability and public health.

Awards 🏆

Throughout her career, Christy has received several prestigious awards, including the Dean’s Trophy for the Best Publication in 2023 and multiple postdoctoral fellowships from renowned organizations such as the Whole and Retail Sector Education Training Authority and the National Research Foundation of South Africa. She was also recognized as the Best Student in Research Project by The American Society of Microbiology in 2007 and received the Senate Prize for Best Student in Microbiology during her undergraduate studies.

Publications  Top Notes📚

Christy has made significant contributions to the field of microbiology, authoring numerous research articles in peer-reviewed journals. Below is a selection of her notable publications:

  1. Manyi-Loh, C.E., Lues, R. (2023). A South African Perspective on the Microbiological and Chemical Quality of Meat: Plausible Public Health Implications. Microorganisms, 11, 2484. Link
    Cited by: Cite This Article
  2. Manyi-Loh, C.E.; Lues, R. (2023). Anaerobic Digestion of Lignocellulosic Biomass: Substrate Characteristics (Challenge) and Innovation. Fermentation, 9, 755. Link
    Cited by: Cite This Article
  3. Manyi-Loh, C.E.; Okoh, A.I.; Lues, R. (2023). Occurrence and Multidrug Resistance in Strains of Listeria monocytogenes Recovered from the Anaerobic Co-Digestion Sludge Contained in a Single Stage Steel Biodigester: Implications for Antimicrobial Stewardship. Microorganisms, 11, 725. Link
    Cited by: Cite This Article
  4. Manyi-Loh, C.E., Okoh, A.I., Lues, R. (2023). Prevalence of Multidrug-Resistant Bacteria (Enteropathogens) Recovered from a Blend of Pig Manure and Pinewood Saw Dust during Anaerobic Co-Digestion in a Steel Biodigester. International Journal of Environmental Research and Public Health, 20, 984. Link
    Cited by: Cite This Article
  5. Manyi-Loh, C.E., Lues, R. (2022). Reduction in Bacterial Pathogens in a Single Stage Steel Biodigester Co-Digesting Saw Dust and Pig Manure at Psychrophilic Temperature. Applied Sciences, 12. Link
    Cited by: Cite This Article

TOSHIFUMI OHKUSA | Microbiology | Best Researcher Award

Posted on by World Top Scientists

Prof. TOSHIFUMI OHKUSA | Microbiology | Best Researcher Award

Special Professor, juntendo, Japan

Dr. Toshifumi Ohkusa is a highly regarded expert in gastroenterology and microbiota research, with a distinguished career spanning over four decades. He is currently a Special Professor at the Department of Microbiota Research at Juntendo University Graduate School of Medicine. Dr. Ohkusa has made significant contributions to the field of gastroenterology, particularly in understanding ulcerative colitis and intestinal microflora. 🌟👨‍⚕️

Publication profile

Scopus

 

Education

Dr. Ohkusa completed his medical degree (M.D.) from Tokyo Medical and Dental University in 1978. He pursued a Ph.D. from the same institution, where his groundbreaking research on ulcerative colitis in hamsters through dextran sulfate sodium and changes in intestinal microflora earned him a doctorate in 1986. 🎓📚

Experience

With an impressive academic journey, Dr. Ohkusa served as a Research Associate and Instructor at Tokyo Medical and Dental University from 1986 to 2001. He later joined Juntendo University, where he advanced from Assistant Professor to Associate Professor in the Department of Gastroenterology. Between 2008 and 2017, he held the prestigious position of Professor at The Jikei University Kashiwa Hospital. Currently, he leads microbiota research at Juntendo University. 💼🔬

Research Focus

Dr. Ohkusa’s research focuses on gastroenterology, particularly the mechanisms of ulcerative colitis and the role of intestinal microflora in gastrointestinal diseases. His work on microbiota research has significantly advanced the understanding of gastrointestinal health. 🔬🧫

Awards and Honors

Dr. Ohkusa has received numerous accolades for his groundbreaking work in gastroenterology and internal medicine, earning recognition from both Japanese and international medical societies. 🏆🌍

Publication Top Notes

Effect of probiotic bifidobacterium breve in improving cognitive function and preventing brain atrophy in older patients with suspected mild cognitive impairment: Results of a 24-week randomized, double-blind, placebo-controlled trial

Analysis of the NUDT15 gene and metabolites of azathioprine in Japanese patients with inflammatory bowel disease

Correction: The insoluble excretion of multi-matrix system mesalazine preparations in patients with ulcerative colitis (BMC Gastroenterology, (2022), 22, 1, (390), 10.1186/s12876-022-02474-9)

khadijeh dizajiasl | Microbiology Award | Outstanding Scientist Award

Posted on by World Top Scientists

Assist Prof Dr khadijeh dizajiasl | Microbiology Award | Outstanding Scientist Award

Assist Prof Dr khadijeh dizajiasl, azad university of tabriz , Iran

 Khadijeh Dizaji Asl is an Assistant Professor at Azad University of Medical Sciences, Tabriz. Born on November 2, 1983, in Tabriz, Iran, she holds a B.Sc. in Radiology, an M.Sc., and a Ph.D. in Anatomical Sciences from Tabriz University of Medical Sciences. Her research focuses on NK cell therapy in leukemia and the impact of telomerase inhibition on cancer cells. Khadijeh has authored several impactful publications in renowned journals and has received recognition as an Outstanding PhD student. She is also noted for her teaching in anatomy and histology. 🧬

Publication Profile

Goolge scolar

Education

Khadijeh Dizaji Asl pursued a diverse academic journey at Tabriz University of Medical Sciences in Iran, beginning with a B.Sc. in Radiology from 2011 to 2013. She then continued her studies with an M.Sc. in Anatomical Sciences from 2014 to 2016, followed by a Ph.D. in the same field from 2016 to 2022. Her educational path reflects a deep commitment to advancing her expertise in medical sciences, particularly in anatomical research and its applications. Throughout her studies, Khadijeh has demonstrated a passion for knowledge and a dedication to contributing significantly to her field. 🎓

Experience: 💼

 📚 Khadijeh Dizaji Asl is a dedicated educator and researcher specializing in Anatomy and Histopathology. She began her teaching career at Tabriz University of Medical Sciences from 2019 to 2021, instructing courses in Gross Anatomy, Embryology, Histology for Midwives, Operating Room students, and Neuroanatomy for Dentistry students. Currently serving at Islamic Azad University, Tabriz branch, she continues to impart knowledge in Anatomy, Histology, and Embryology since 2021. Additionally, Khadijeh holds the roles of Assistant Professor and Head of the Anatomy and Histopathology Department at Islamic Azad University, Tabriz branch, where she shapes the future of medical education through her expertise and leadership. 🎓

Awards and Honors: 🏆

Khadijeh Dizaji Asl is a distinguished academic and researcher, recognized for her outstanding achievements in the field of anatomical sciences. She earned accolades such as being named the Outstanding PhD student in 2020 and the Educational Outstanding Student during her Master’s studies in 2016. Her contributions are further underscored by her paper being among the top downloads on Wiley. Currently an Assistant Professor and Head of the Anatomy and Histopathology Department at Islamic Azad University, Tabriz branch, Khadijeh continues to excel in both teaching and advancing scientific knowledge in her specialized field. 🧬

Research Focus

Khadijeh Dizaji Asl’s research primarily revolves around immunotherapy and cellular mechanisms in cancer treatment, focusing specifically on Natural Killer (NK) cells and their application in acute myeloid leukemia (AML), leukemia cell lines, and other malignancies. Her studies explore innovative approaches such as CAR-NK cell therapy and the effects of telomerase inhibition on NK cell activity. She investigates the role of KIR-positive NK cells in disease progression and therapeutic interventions. Additionally, Khadijeh explores the impact of NK cell dysfunction in infectious diseases like SARS-CoV-2. Her research aims to advance understanding and improve clinical outcomes through targeted immunotherapies. 🧬

Publications Top Notes

Therapeutic potential of neurotrophic factors in Alzheimer’s Disease Cited by 27, 2022 📖

Comparison of characteristics of human amniotic membrane and human adipose tissue derived mesenchymal stem cells Cited by 27, 2017 📖

Effect of aberrant DNA methylation on cancer stem cell properties Cited by 25, 2022 📖

The role of KIR positive NK cells in diseases and its importance in clinical intervention Cited by 24, 2021 📖

Telomerase inhibition on acute myeloid leukemia stem cell induced apoptosis with both intrinsic and extrinsic pathways Cited by 23, 2022 📖

Telomerase‐based therapies in haematological malignancies Cited by 9, 2022 📖

A combination of telomerase inhibition and NK cell therapy increased breast cancer cell line apoptosis Cited by 7, 2023 📖

The effect of telomerase inhibition on NK cell activity in acute myeloid leukemia Cited by 7, 2023 📖

NK cell dysfunction is linked with disease severity in SARS‐CoV‐2 patients Cited by 7, 2022 📖

Bone marrow CD34 positive cells may be suitable for collection after death Cited by 3, 2022 📖

Inhibition of mitochondria induces apoptosis and reduces telomere length and activity in acute myeloid leukemia stem cells